Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. DSX
3. GNK
4. INTC
5. ACN
6. III
7. SAN
8. TTEC
9. SNY
10. DAL

Go back to Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
(NASDAQ: IVVD) Delayed: 0.97 +0.04 (4.30%)
Previous Close $0.93    52 Week High $ 
Open $0.94    52 Week Low $ 
Day High $1.01    P/E N/A 
Day Low $0.90    EPS $ 
Volume 21,078,806       

(NASDAQ: IVVD) Delayed: 0.97 +0.04 (4.30%)
Previous Close $0.93    52 Week High $ 
Open $0.94    52 Week Low $ 
Day High $1.01    P/E N/A 
Day Low $0.90    EPS $ 
Volume 21,078,806